Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. | 5,213 | reported | 10 Feb 2020 | tx 2+36,488 |
| Bioverativ Inc. | 0 | reported | 08 Mar 2018 | tx 28+277,757−174,339.25 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Feb 2020 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 5,213 | 0.00 USD | |
| 10 Feb 2020 | GRANT_AWARD | Apellis Pharmaceuticals, Inc. | 31,275 | 0.00 USD | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 20,396.25 | — | |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 31,818 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 29,797 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 59,595 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 14,899 | — | deriv |
| 08 Mar 2018 | OTHER | Bioverativ Inc. | 7,489 | — | deriv |
| 22 Feb 2018 | TAX_WITHHOLDING | Bioverativ Inc. | 1,235 | 104.30 USD | |
| 23 Feb 2018 | TAX_WITHHOLDING | Bioverativ Inc. | 389 | 104.74 USD | |
| 14 Feb 2018 | TAX_WITHHOLDING | Bioverativ Inc. | 1,141 | 103.52 USD | |
| 14 Feb 2018 | EXERCISE | Bioverativ Inc. | 3,744 | 0.00 USD | |
| 14 Feb 2018 | EXERCISE | Bioverativ Inc. | 3,744 | 0.00 USD | deriv |
| 31 Jan 2018 | GRANT_AWARD | Bioverativ Inc. | 31,818 | 0.00 USD | deriv |
| 02 Nov 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 318 | 53.65 USD | |
| 28 Feb 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 182 | 49.56 USD | |
| 28 Feb 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 592 | 47.76 USD | |
| 28 Feb 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 790 | 43.42 USD | |
| 28 Feb 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 301 | 43.42 USD | |
| 28 Feb 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 768 | 47.76 USD | |
| 28 Feb 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 235 | 49.56 USD | |
| 28 Feb 2017 | GRANT_AWARD | Bioverativ Inc. | 22,567 | 0.00 USD | |
| 28 Feb 2017 | TAX_WITHHOLDING | Bioverativ Inc. | 650 | 43.42 USD | |
| 14 Feb 2017 | GRANT_AWARD | Bioverativ Inc. | 14,872 | 0.00 USD | deriv |
| 14 Feb 2017 | GRANT_AWARD | Bioverativ Inc. | 29,744 | 0.00 USD | deriv |